Esculeoside A, a glycoside of spirosolane-type, is identified as a major component in ripe tomato fruits. Our previous study showed that esculeoside A inhibited hyaluronidase activity in vitro and ameliorated experimental dermatitis in vivo. The aim of this present study is to investigate the inhibition mode on mammalian hyaluronidase by esculeoside A. Measured by a modified Morgan-Elson method, the present kinetic analysis of the hydrolysis reaction using hyaluronic acid revealed that no significant difference was observed in velocity maximum V max , and Michaelis-Menten constant K m was shown as 0.74 mM in the absence of esculeoside A, was increased as 1.32 and 1.98 mM with 3 and 30 μM of esculeoside A, respectively. Thus suggested that the inhibition mode on hyaluronidase by esculeoside A was competitive. This competitive inhibition on hyaluronidase activity may become valuable in the amelioration of mice experimental dermatitis by esculeoside A. Hyaluronidase, an enzyme for hyaluronic acid (HA) degradation, is well known to be related with inflammation and allergic responses [1] . It has been reported that during inflammation and tissue damage, hyaluronidase cleaves polysaccharide HA in low molecular weight HA fragments [2], which induce pro-inflammatory cytokine production, modulating both innate and acquired immune response of these cells [3] . Moreover, the experimental dermatitis was completely prevented by a hyaluronidase inhibitor [4, 5] . Therefore, the anti-hyaluronidase activity may play an essential role during the pathological processes of skin inflammation and allergy.
Hyaluronidase, an enzyme for hyaluronic acid (HA) degradation, is well known to be related with inflammation and allergic responses [1] . It has been reported that during inflammation and tissue damage, hyaluronidase cleaves polysaccharide HA in low molecular weight HA fragments [2] , which induce pro-inflammatory cytokine production, modulating both innate and acquired immune response of these cells [3] . Moreover, the experimental dermatitis was completely prevented by a hyaluronidase inhibitor [4, 5] . Therefore, the anti-hyaluronidase activity may play an essential role during the pathological processes of skin inflammation and allergy.
Heparin [6] , flavonoids [7] , and tea saponins [8] have been reported to inhibit mammalian hyaluronidase activity in vitro, but most of these compounds show weak inhibitory activity on hyaluronidase. On the other hand, Nohara and co-workers have succeeded in isolating of esculeoside A [9] , a glycoside of spirosolane type, from fresh tomato fruit (Lycopersicon esculentum). Esculeoside A is identified as a major component in ripe tomatoes [10] , at 4-fold the content of lycopene, the main tomato carotenoid. We have previously reported [11] the ameliorating effects of esculeoside A on 2, 4-dinitrochlorobenzene (DNCB)-induced dermatitis of mice. We also found that esculeoside A potently inhibited hyaluronidase activity in vitro, but the analysis of inhibition mode is still lacking.
In this study, firstly, the effects of esculeoside A, chromoglycate and suplatast on hyaluronidase activity were determined in vitro ( Figure 1 ). As shown in Figure 1B , esculeoside A inhibited hyaluronidase activity in a concentration-dependent manner, and IC 50 value was about 6.5 μM. Chromoglycate induced concentration-dependent inhibition on hyaluronidase with 30 μM of IC 50 . These indicate that the inhibitory effect of esculeoside A on hyaluronidase activity is stronger than that of chromoglycate, an anti-allergic agent, known as a mast cell stabilizer which inhibits the release of mediators, such as histamine and leukotrienes. Meanwhile, the hyaluronidase activity was not inhibited significantly by suplatast, another anti-allergic agent. Suplatast is able to alleviate cutaneous symptoms of atopic dermatitis and nasal symptoms of allergic rhinitis by inhibiting the production of Th2 cytokine and immunoglobulin E [14, 15] , and suppress also histamine release and H1 receptor expression [16] . Thus, the present data suggest that further research in chemical mediator release is warranted for molecular targets of anti-allergic therapeutic effects of esculeoside A.
A.
B. The structure of esculeoside A consists of two hydrophilic parts (a tetrasaccharide side chain and a monosaccharide side chain), a hydrophobic part (the steroidal moiety esculeogenin A), and a polar-NH group. These unique features of the molecule govern its biological activities. Our previous study suggested that the inhibition of esculeogenin A on hyaluronidase activity was stronger than that of esculeoside A in vitro [11] . Tomato fruit are eaten by the diet, and dermal hyaluronidase expression and activity are not altered by topical treatment with glucocorticoids [17] , thus, it should be important to analyze detailed mechanism on the inhibition of hyaluronidase activity by esculeoside A not by its aglycon, esculeogenin A. The competitive inhibition on representative mammalian hyaluronidase indicated that esculeoside A should bind to the active center of hyaluronidase. It has reported that there is an extended, hydrophobic channel formed by mostly conserved amino acids in bovine testicular hyaluronidase. Lascorbic acid has been described [18, 19] as a competitive inhibitor of hyaluronidase, and L-ascorbic acid 6-hexadecanoate owing its additional hydrophobic interactions in the active site led to increased inhibition. Therefore, it seems that the hydrophobic steroidal moiety of esculeoside A may interact with the hydrophobic active center of hyaluronidase, and that bulky tetrasaccharide side chain may interfere with the entrance of substrate hyaluronic into the same centers. Detail analysis on the binding mode of esculeoside A to hyaluronidase remains needed.
Whereas, our previous study found that oral treatment with esculeoside A 10 mg/kg decreased significantly the dermatitis scores, epidermal and dermal thickening and inflammatory cell infiltration in DNCB-induced dermatitis mice. It has been reported that contact sensitizer with 2, 4, 6-trinitrochlorobenzene (TNCB) induced increase of hyaluronidase activity and breakdown of the extracellular matrix component HA to pro-inflammatory low molecular weight fragments in the ear skin [5] . Furthermore, in an in vitro model of human keratinocytes, DNCB treatment was shown to stimulate hyaluronidase 1 and 2 expressions inducing HA degradation [20] . These findings suggested a beneficial role for hyaluronidase inhibitors in prevention and treatment of experimental dermatitis. In continuation, low molecular weight HA fragment was able to induce pro-inflammatory cytokine production necessary for maturation and migration of dendritic cells via TLR4, and T cells activation [21, 22] , and leaded to skin inflammation. Therefore, the competitive inhibition of hyaluronidase by esculeoside A may become valuable in therapeutic effect of experimental dermatitis. Future work is to investigate if there is a direct mechanism on the amelioration of experimental dermatitis by esculeoside A involving HA receptor CD44, hyaluronidase expression and innate immune signaling.
Experimental
Preparation of Esculeoside A: Esculeoside A were extracted as previously described [9, 12] . Briefly, fresh ripe cherry tomato fruits were smashed and then filtered. The supernatant was applied to column chromatography over a porous polystyrene gel (Diaion HP-20), and washed with water, then the methanol extract was passed through a reverse silica gel column chromatography, and then eluted with 60% methanol. These methanol eluates was checked on TLC with chloroform-methanol-water (6 : 4 : 1). Then, the obtained tomato saponin was identified by NMR spectrum. The average of esculeoside A yield from ripe tomato fruits was calculated as about 0.043%. The chemical structure of esculeoside A was shown in Figure 1A .
Hyaluronidase Inhibitory Assay: The inhibitory activity on hyaluronidase was measured according to a modified Morgan-Elson method as described previously [13] . Briefly, 4 mg/mL of hyaluronidase (Type IV-S: From Bovine Testes, Sigma-Aldrich, St. Louis, U.S.A.) prepared in 0.1 M acetate buffer (pH 4) was preincubated with different concentrations of samples at 37°C for 20 min. Then, 0.1 mg/mL of compound 48/80 (Sigma, St. Louis, U.S.A.) in buffer was added as an activator of hyaluronidase and incubated for 20 min. After 0.4 mg/mL of hyaluronic acid sodium salt (from Rooster Comb, Wako, Osaka, Japan) in buffer had been included, the mixture was incubated at 37 °C for 40 min. Reaction was terminated by the addition of pH 9.1 H 3 BO 3 solution, and pdimethylaminobenzaldehyde (Wako, Osaka, Japan) acetate solution was added and incubated. Then the absorbance was determined at 585 nm, and the enzyme inhibitory activity (%) was calculated by subtracting activity in the presence of the samples from that in their absence. All samples were diluted with 0.1 M acetate buffer. 2.8 mg/mL of esculeoside A as a stock solution was prepared with 0.7% DMSO. Disodium chromoglycate (Wako, Osaka, Japan) and suplatast tosylate (ICI, Tokyo, Japan) were prepared with water as a stock solution of 10 mg/mL.
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Competitive inhibition of hyaluronidase by esculeoside A Natural Product Communications Vol. 13 (11) Statistical Analysis: All data are the mean ± S.E.M. Comparisons between the two groups were performed with a Student's t-test. Probability (p) values less than 0.05 were considered to be statistically significant. All statistical analyses were performed with Prism 5.0 (GraphPad Software, San Diego, USA).
